A genetic variant is likely putting some children suffering with myocarditis — inflammation of the heart muscle — at higher risk of developing heart failure, which can be fatal, according to a study ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...